Metraipolis › archive › dc_8a4eaf567471
Evaluating the impact of Brexit on the pharmaceutical industry — Europe PMC PMID:29034096
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/29034096
- DOI
- 10.1186/s40545-017-0120-z
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T06:45:52.921Z
- SHA-256 of the archived text
68367c98415b9fd5c4dcd133607e903c4b75c0965f47c07a0af2b91c6f80a3e9- Stable URL of this page
https://metraipolis.com/documento/dc_8a4eaf567471
How to cite
Evaluating the impact of Brexit on the pharmaceutical industry — Europe PMC PMID:29034096 — Europe PMC (en), https://europepmc.org/article/MED/29034096 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8a4eaf567471 (Metraipolis archive dc_8a4eaf567471, sha256 68367c98415b9fd5c4dcd133607e903c4b75c0965f47c07a0af2b91c6f80a3e9)
BibTeX
@misc{dc8a4eaf567471,
title = {Evaluating the impact of Brexit on the pharmaceutical industry — Europe PMC PMID:29034096},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/29034096},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8a4eaf567471; sha256 68367c98415b9fd5c4dcd133607e903c4b75c0965f47c07a0af2b91c6f80a3e9},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/29034096. Agents can read the archived copy with the MCP tool read_document.